Good evening :)
Place Order
Add to Watchlist
Home
Portfolio
Search
GoldGold
More

Bharat Parenterals Ltd

BPLPHARMA

Bharat Parenterals Ltd

BPLPHARMA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,133 cr, stock is ranked 1,432
High RiskStock is 3.56x as volatile as Nifty
1,618.251.39% (-22.75)
1,618.251.39% (-22.75)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,133 cr, stock is ranked 1,432
High RiskStock is 3.56x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,133 cr, stock is ranked 1,432
High RiskStock is 3.56x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-409.664.730.05%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.716.630.52%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Bharat Parenterals Limited is a pharmaceutical company that makes pharmaceutical formulations. Its products include general, beta-lactam, cephalosporins, antiretroviral, and veterinary.

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 2.75%, vs industry avg of 9.03%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.11% to 0.07%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of -7.33%, vs industry avg of 15.27%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue128.82119.11143.69232.24239.66213.31219.79229.72265.95302.43
Raw Materialssubtract83.8880.5088.81142.09151.88132.47134.39147.23173.54287.34
Power & Fuel Costsubtract1.871.792.622.703.193.103.213.754.69
Employee Costsubtract9.1011.3712.9415.3715.5814.7515.3718.0022.78
Selling & Administrative Expensessubtract13.696.4012.3621.6421.6514.0413.8723.6728.80
Operating & Other expensessubtract5.254.887.658.867.8115.0417.115.044.33
Depreciation/Amortizationsubtract4.205.795.576.135.886.036.665.889.0223.73
Interest & Other Itemssubtract1.490.910.940.870.860.771.312.604.077.39
Taxes & Other Itemssubtract2.890.593.6813.358.656.746.837.104.21-13.28
EPS11.2612.0115.9237.0542.1735.5536.5828.4925.03-4.73
DPS0.000.000.000.000.000.000.000.751.001.00
Payout ratio0.000.000.000.000.000.000.000.030.04-0.21
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2017

Annual report

PDF
FY 2018

Annual report

PDF
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
FY 2024

Annual report

PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Bharat Parenterals Ltd77.644.730.05%
Sun Pharmaceutical Industries Ltd45.126.440.75%
Cipla Ltd28.854.440.88%
Torrent Pharmaceuticals Ltd69.1016.690.83%

Price Comparison

Compare BPLPHARMA with any stock or ETF
Compare BPLPHARMA with any stock or ETF
BPLPHARMA
Loading...

Shareholdings

Promoter Holdings Trend

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

No institutional holdings trend are available

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding67.20%0.00%0.54%0.08%32.18%

Mar 2024

Jun 2024

Sep 2024

Oct 2024

Shareholding History

SepDec '23MarJunSepOct0.00%0.00%0.00%0.00%0.08%0.08%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJun 25, 2024

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Jun 25, 2024

Cash Dividend

Ex DateEx DateSep 25, 2023

Final
Final | Div/Share: ₹0.75

Dividend/Share

₹0.75

Ex DateEx Date

Sep 25, 2023

News & Opinions
Earnings
Bharat Parenterals reports consolidated net loss of Rs 7.51 crore in the September 2024 quarter

Net loss of Bharat Parenterals reported to Rs 7.51 crore in the quarter ended September 2024 as against net profit of Rs 3.52 crore during the previous quarter ended September 2023. Sales rose 19.76% to Rs 71.63 crore in the quarter ended September 2024 as against Rs 59.81 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales71.6359.81 20 OPM %-10.697.22 - PBDT-6.366.29 PL PBT-15.374.54 PL NP-7.513.52 PL Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Bharat Parenterals to announce Quarterly Result

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 29 October 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Bharat Parenterals consolidated net profit declines 82.98% in the June 2024 quarter

Net profit of Bharat Parenterals declined 82.98% to Rs 1.28 crore in the quarter ended June 2024 as against Rs 7.52 crore during the previous quarter ended June 2023. Sales rose 32.33% to Rs 92.51 crore in the quarter ended June 2024 as against Rs 69.91 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales92.5169.91 32 OPM %4.8514.95 - PBDT4.2611.66 -63 PBT-4.7710.08 PL NP1.287.52 -83 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Bharat Parenterals announces board meeting date

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 8 August 2024Powered by Capital Market - Live

4 months agoCapital Market - Live

Bharat Parenterals shares surge on Q1 results

1 year agoThe Hindu Businessline

Bharat Parenterals consolidated net profit rises 113.76% in the March 2022 quarter

2 years agoBusiness Standard

Bharat Parenterals consolidated net profit rises 23.26% in the September 2021 quarter

3 years agoBusiness Standard

Bharat Parenterals standalone net profit rises 24.34% in the September 2021 quarter

3 years agoBusiness Standard

Bharat Parenterals consolidated net profit rises 16.42% in the June 2021 quarter

3 years agoBusiness Standard

Bharat Parenterals consolidated net profit declines 73.49% in the March 2021 quarter

3 years agoBusiness Standard